Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.16.3.1 (ceruloplasmin)
 5,074 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A method for the speciation of zinc and copper binding with proteins in human serum was explored by chelating resin (Chelex-100) pre-treatment and inductively coupled plasma mass spectrometry (ICP-MS). It was shown by a SEC (size-exclusion chromatography)-ICP-MS system that albumin-zinc and albumin-copper (loosely-bound species) could be selectively removed from serum by adsorption on the Chelex-100 resin after the chelating resin pre-treatment, while alpha 2-macroglobulin-zinc and ceruloplasmin-copper (firmly-bound species) remained in the serum. The zinc and copper bound with alpha 2-macroglobulin and ceruloplasmin, respectively, were then determined by ICP-MS after batch treatment of the serum samples with the Chelex-100 resin. In addition, the total concentrations of zinc and copper were also determined by ICP-MS after a 20-fold dilution with 0.1 M HNO3. The albumin-zinc and -copper were estimated as the differences between the concentrations of total and firmly-bound species. The present batch pre-treatment method was applied to the speciation analysis of zinc and copper binding with proteins in sera donated from 25 healthy volunteers as well as from a pregnant woman and a myelodysplastic syndrome patient. The observed concentrations of alpha 2-macroglobulin-zinc and ceruloplasmin-copper were in the ranges 109-202 ng ml-1 (12.4-31.3% of total zinc) and 513-880 ng ml-1 (90.6-99.7% of total copper), respectively. The present method is simple (only addition of the chelating resin and centrifugation is required) and reproducible (average RSD = 2% for alpha 2-macroglobulin-zinc and 1% for ceruloplasmin-copper in intra-assay measurements, and 5% for alpha 2-macroglobulin-zinc and 4% for ceruloplasmin-copper in inter-assay measurements), and there is less risk of contamination during separation.
 ...
PMID:Speciation of protein-binding zinc and copper in human blood serum by chelating resin pre-treatment and inductively coupled plasma mass spectrometry. 1088 75

The article solves a current task concerning a substantiated use of acetylation phenotype as susceptibility biomarker to unfavourable effect of chemical substances in scientific studies. Objective: to study a combined effect of sodium nitrate and cadmium chloride on the prooxidant-antioxidant balance of the blood, liver and functional state of the central nervous system in young rats with different acetylation type. The experimental studies were performed on immature male rats 1,5-month of age. The experimental animals were divided into two groups according to the amount of general sulfadimine excreted with urine: "rapid" and "slow" acetylators. 2 subgroups were differentiated in every group: I - control animals, II - animals subjected to administration of cadmium chloride and sodium nitrate. Administration of sodium nitrate and cadmium chloride to animals in the doses 1/15 DL50 and 1/150 DL50 respectively during 14 days found that at the young age "slow" acetylation type is susceptibility marker, and the criteria of a harmful effect in them are the following: 25% increase protein peroxide oxidation in the blood plasma, 34% and 30% increase of average molecular peptides and ceruloplasmin respectively, and 6,7 times increase of methemoglobin (hemiglobin) concentration. Nitrate-cadmium intoxication caused inhibition of the integral behavioural activity both in slow and rapid acetylators. Disturbed behavioural activity in young animals with "slow" acetylation type under conditions of subacute effect of sodium nitrate and cadmium chloride is caused mainly by an increased content of liver lipoperoxidation secondary products and less - by the levels of average molecular peptides and ceruloplasmin in the blood plasma, and in "rapid" acetylators - by increased products of oxidation-modification proteins.
 ...
PMID:ACETYLATION PHENOTYPE AS A SUSCEPTIBILITY MARKER FOR DEVELOPMENT OF NITRATE-CADMIUM INTOXICATION IN YOUNG RATS. 3141 39